Title: Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients
Authors: Balti, Eric V ×
Vandemeulebroucke, Evy
Weets, Ilse
Van De Velde, Ursule
Van Dalem, Annelien
Demeester, Simke
Verhaeghen, Katrijn
Gillard, Pieter
De Block, Christophe
Ruige, Johannes
Keymeulen, Bart
Pipeleers, Daniel G
Decochez, Katelijn
Gorus, Frans K
The Belgian Diabetes Registry #
Issue Date: Feb-2015
Publisher: Issued for the Endocrine Society by the Williams & Wilkins Co.
Series Title: Journal of Clinical Endocrinology & Metabolism vol:100 issue:2 pages:551-560
Abstract: Context and Objective: In preparation of future prevention trials, we aimed to identify predictors of 3-year diabetes onset among OGTT- and hyperglycemic clamp-derived metabolic markers in persistently islet autoantibody positive (autoAb(+)) offspring and siblings of patients with type 1 diabetes (T1D). Design: Registry-based study. Setting: Functional tests were performed in hospital setting. Participants: Persistently autoAb(+) first-degree relatives of patients with T1D (n=81; age 5-39 years). Main outcome measures: We assessed 3-year predictive ability of OGTT- and clamp-derived markers using receiver operating characteristics (ROC) and Cox regression analysis. Area under the curve of clamp-derived first-phase C-peptide release (AUC5-10min; min 5-10) was determined in all relatives and second-phase release (AUC120-150min; min 120-150) in those aged 12-39 years (n=62). Results: Overall, the predictive ability of AUC5-10min was better than that of peak C-peptide, the best predictor among OGTT-derived parameters (ROC-AUC [95%CI]: 0.89 [0.80-0.98] vs. 0.81 [0.70-0.93]). Fasting blood glucose (FBG) and AUC5-10min provided the best combination of markers for prediction of diabetes within three years; (ROC-AUC [95%CI]: 0.92 [0.84-1.00]). In multivariate Cox regression analysis, AUC5-10min (P=.001) was the strongest independent predictor and interacted significantly with all tested OGTT-derived parameters. AUC5-10min below percentile 10 of controls was associated with 50-70% progression to T1D regardless age. Similar results were obtained for AUC120-150min Conclusions: Clamp-derived first-phase C-peptide release can be used as an efficient and simple screening strategy in persistently autoAb(+) offspring and siblings of T1D patients to predict impending diabetes.
ISSN: 0021-972X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Balti et al JCEM 2014.pdf Accepted 523KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science